Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New golden era of chelation therapy in thalassaemia: the achievement and maintenance of normal range body iron stores.

× No keyword cloud information.

8 in total

1. New developments and controversies in iron metabolism and iron chelation therapy.

Authors: Christina N Kontoghiorghe; George J Kontoghiorghes
Journal: World J Methodol Date: 2016-03-26

Review 2. World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients.

Authors: Christina N Kontoghiorghe; Nicholas Andreou; Katerina Constantinou; George J Kontoghiorghes
Journal: World J Methodol Date: 2014-09-26

Review 3. How we manage iron overload in sickle cell patients.

Authors: Thomas D Coates; John C Wood
Journal: Br J Haematol Date: 2017-03-14 Impact factor: 6.998

4. Iron overload in transfusion-dependent patients.

Authors: Thomas D Coates
Journal: Hematology Am Soc Hematol Educ Program Date: 2019-12-06

Review 5. Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases.

Authors: Annita Kolnagou; Christina N Kontoghiorghe; George J Kontoghiorghes
Journal: World J Methodol Date: 2014-12-26

Review 6. The History of Deferiprone (L1) and the Paradigm of the Complete Treatment of Iron Overload in Thalassaemia.

Authors: George J Kontoghiorghes; Marios Kleanthous; Christina N Kontoghiorghe
Journal: Mediterr J Hematol Infect Dis Date: 2020-01-01 Impact factor: 2.576

Review 7. Management of Iron Overload in Beta-Thalassemia Patients: Clinical Practice Update Based on Case Series.

Authors: Valeria Maria Pinto; Gian Luca Forni
Journal: Int J Mol Sci Date: 2020-11-20 Impact factor: 5.923

8. A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?

Authors: Alessandro Riva
Journal: Expert Opin Drug Saf Date: 2013-08-12 Impact factor: 4.250

8 in total